Stock Fundamentals

Company Information

Company Name
89bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US2825591033
CIK: 0001785173
CUSIP: 282559103
Currency: USD
Full Time Employees: 93
Phone: 415 432 9270
Fiscal Year End: December
IPO Date: Nov 11, 2019
Description:

89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. 89bio, Inc. was formerly known as The company was founded in 2018 and is based in San Francisco, California. As of October 29, 2025, 89bio, Inc. operates as a subsidiary of Roche Holding AG.

Address:

655 Montgomery Street, San Francisco, CA, United States, 94111

Directors & Officers

Name Title Year Born
Mr. Rohan Palekar CEO & Director 1966
Mr. Ryan Stephen Martins Chief Financial Officer 1978
Mr. Francis W. Sarena J.D. Chief Operating Officer 1971
Mr. Quoc Le-Nguyen Chief Technical Officer 1968
Dr. Harry Mansbach M.D. Chief Medical Officer 1965
Mr. Shiva K. Natarajan CPA Senior Vice President of Finance & Principal Accounting Officer 1966
Ms. Annie J. Chang M.B.A. VP of Investor Relations & Corporate Communications NA
Ms. Amanda Kurihara Vice President of People & Culture NA
Ms. Melissa Abel Senior Vice President of Commercial Strategy NA
Mr. Michael Baldwin Senior VP & Head of Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jul 15, 2025 Quoc Le-Nguyen N/A Sale 10.46K $11.02 $115.28K
Apr 15, 2025 Quoc Le-Nguyen N/A Sale 15.33K $5.95 $91.21K
Jan 30, 2025 Ra Capital Management, L.P. N/A Purchase 5.71M $8.75 $50.00M
Jan 21, 2025 Charles Mcwherter N/A Purchase 5.00K $6.55 $32.75K
Jan 15, 2025 Quoc Le-Nguyen N/A Sale 10.96K $6.49 $71.15K
Dec 06, 2024 Rohan Palekar N/A Purchase 5.00K $7.89 $39.45K
Dec 05, 2024 Charles Mcwherter N/A Purchase 10.00K $8.00 $80.00K
Nov 22, 2024 Rohan Palekar N/A Purchase 10.00K $8.35 $83.50K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HHG PLC 20.79M Jun 30, 2025 14.02% $0.10 1.59%
RA Capital Management, LLC 19.89M Jun 30, 2025 13.41% $3.29 0.00%
Suvretta Capital Management, LLC 14.21M Jun 30, 2025 9.58% $4.21 -0.87%
BlackRock Inc 10.57M Jun 30, 2025 7.13% $0.00 4.90%
Deep Track Capital, LP 9.50M Jun 30, 2025 6.41% $2.99 1.97%
Vanguard Group Inc 8.24M Jun 30, 2025 5.56% $0.00 15.06%
venBio Select Advisor LLC 6.75M Jun 30, 2025 4.55% $1.16 6.30%
State Street Corp 4.25M Jun 30, 2025 2.87% $0.00 5.45%
Pictet Asset Manangement SA 4.04M Jun 30, 2025 2.72% $0.04 -4.03%
Citadel Advisors Llc 3.84M Jun 30, 2025 2.59% $0.01 -24.57%
Westfield Capital Management Company, L.P. 3.37M Jun 30, 2025 2.27% $0.14 -13.45%
Geode Capital Management, LLC 3.11M Jun 30, 2025 2.10% $0.00 7.36%
Holocene Advisors, LP 3.07M Jun 30, 2025 2.07% $0.07 0.00%
Polar Capital Holdings PLC 2.48M Jun 30, 2025 1.67% $0.13 -1.00%
Point72 Asset Management, L.P. 2.27M Jun 30, 2025 1.53% $0.04 0.00%
Morgan Stanley - Brokerage Accounts 2.19M Jun 30, 2025 1.47% $0.00 247.25%
Assenagon Asset Management SA 2.17M Jun 30, 2025 1.46% $0.03 406.23%
SILVERARC CAPITAL MANAGEMENT, LLC 2.04M Jun 30, 2025 1.37% $3.69 34.86%
Adage Capital Partners Gp LLC 1.97M Jun 30, 2025 1.33% $0.03 0.00%
RTW INVESTMENTS, LLC 1.97M Jun 30, 2025 1.33% $0.28 0.00%

Shares Statistics

Shares Outstanding: 148.49M
Shares Float: 97.04M
% Insiders: 59.50%
% Institutions: 10,369.10%
Short % Float: 6.30%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.70M 3.17% ▼ 2.18% Jul 31, 2025
2 iShares Russell 2000 ETF 3.00M 2.02% ▲ 0.00% Aug 31, 2025
3 Janus Henderson Global Life Sciences 2.92M 1.97% ▼ 1.69% Jun 30, 2025
4 Janus Henderson Global Life Sciences D 2.92M 1.97% ▼ 0.97% Jun 30, 2025
5 Polar Capital Biotech S Inc 2.48M 1.67% ▲ 0.00% Jul 31, 2025
6 Janus Global Life Science AUSD 2.41M 1.63% ▼ 0.18% Jun 30, 2025
7 Janus Henderson Glb Life Scn I2 USD 2.36M 1.59% ▼ 1.79% Jul 31, 2025
8 Janus Henderson Triton D 2.35M 1.58% ▼ 1.17% Jun 30, 2025
9 Janus Henderson US SMID Cap Growth 2.35M 1.58% ▼ 1.17% Jun 30, 2025
10 Janus Henderson US SMID Cap Growth MA 2.35M 1.58% ▲ 0.00% Jun 30, 2025

Valuation Metrics

Enterprise Value: $1.68B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.20B
EBITDA: $-465.64M
Book Value: $3.52
Earnings/Share: $-3.69
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -49.10%
ROE (TTM): -86.86%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 13.19x 0.09x 0.16x -101.57x -0.09x
2023-12-31 20.04x 0.05x 0.10x -42.17x -0.19x
2022-12-31 7.97x 0.13x 0.23x 53.20x -0.20x
2021-12-31 8.29x 0.15x 0.22x -200.77x -0.22x
2020-12-31 25.91x 0.00x 0.04x -345.14x 0.00x
2019-12-31 17.00x 0.00x 0.06x -0.87x 0.00x
2018-12-31 2.60x -0.10x 2.41x N/A -0.10x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ETNB.US!